Rebecca Landy joined DCEG as a postdoctoral fellow in 2018 with a joint appointment in the Biostatistics Branch (BB) and the Clinical Genetics Branch (CGB) Clinical Epidemiology Unit (CGB/CEU). In 2021, she transitioned fully to CGB/CEU. Dr. Landy earned her Ph.D. in epidemiology and statistics from University College London, U.K., under the supervision of Prof. Rebecca Hardy. Her doctoral research focused on missing data in longitudinal studies. Prior to joining NCI, Dr. Landy worked as a statistician at the Centre for Cancer Prevention, Queen Mary University of London with Prof. Peter Sasieni, evaluating cervical cancer screening in England. In June 2021, she was promoted to research fellow.
Dr. Landy is working under the mentorship of Anil Chaturvedi, Ph.D., senior investigator, CGB/CEU, and Hormuzd Katki, Ph.D., senior investigator, BB, to understand the natural history of human papillomavirus-related oropharyngeal cancers, and the appropriate use of risk estimation methods when evaluating cancer screening.